Cipher Mining
CIFR
TeraWulf
WULF
Bitdeer Technologies
BTDR
Bakkt Holdings
BKKT
NEPTUNE DIGITAL ASSETS CORP
NPPTF
US Stock MarketDetailed Quotes
LVTX LAVA Therapeutics
- 1.075
- -0.035-3.15%
Trading Dec 16 13:11 ET
28.27MMarket Cap-1.06P/E (TTM)
1.160High1.010Low138.30KVolume1.090Open1.110Pre Close150.76KTurnover1.14%Turnover RatioLossP/E (Static)26.30MShares6.47052wk High0.86P/B13.00MFloat Cap1.01052wk Low--Dividend TTM12.09MShs Float17.200Historical High--Div YieldTTM13.51%Amplitude1.010Historical Low1.090Avg Price1Lot Size
LAVA Therapeutics Key Stats
EPS
According to the latest financial report of LAVA Therapeutics, the latest earnings per share (TTM) for the company is -0.46. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about LAVA Therapeutics's free cash flow? The latest report shows it as -8.65M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of LAVA Therapeutics shows that the company's current ratio is 5.36, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of LAVA Therapeutics, the quick ratio is 5.26, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of LAVA Therapeutics? The latest ROE figure is -32.41%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of LAVA Therapeutics, the total asset return on investment (ROA) is -14.00%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check LAVA Therapeutics's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of LAVA Therapeutics, the net profit margin is -7.91%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.